Guillain-barré Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-03-12
Clinical Trial Update: Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome [Phase 2]
A Phase 2 clinical trial evaluating efgartigimod for Guillain-Barré syndrome has been withdrawn.
CLINICAL_TRIALS withdrawal · 2022-12-15
Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) [Phase 3]
A Phase 3 trial evaluating Crovalimab for Guillain-Barré Syndrome has been withdrawn.